A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer

Recurrence will develop in 30–50% of colorectal cancer (CRC) cases despite apparent clearance following treatment. Carcinoembryonic antigen (CEA) is the only guideline‐recommended blood test for monitoring cases for recurrence, but its sensitivity and specificity are suboptimal. This observational s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Young, Graeme P., Pedersen, Susanne K., Mansfield, Scott, Murray, David H., Baker, Rohan T., Rabbitt, Philippa, Byrne, Susan, Bambacas, Libby, Hollington, Paul, Symonds, Erin L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5083729/
https://ncbi.nlm.nih.gov/pubmed/27726312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados